No I took your comment "SSH is a buy , the pathway time for CP1...

No I took your comment "SSH is a buy , the pathway time for CP1 and CP2 to get to FDA approval will now be much shorter" to mean that you have some idea of what the steps are and how long it might take.

I was under the impression it will take a number of years to get the CP1 through the various phases required to get to commercialisation but you may have a different view. Hopefully I am wrong and there are a number of shortcuts open to CP2 now that they have some experience and data from CP1, otherwise we are in for a heck of a wait and unlikely to see any real market cap gains until we make some concrete progress. in the meantime it will be important to conserve funds or we will see dilution at a very low share price which would lead to a share price drop and potential consolidation to get the price up over $1 again.